Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
alphabet
biotech
boston blog main
boston top stories
brain
brain-computer interface
broad institute of harvard and mit
brook byers
charles chu
crispr
crispr cas14
deals
decheng capital
diagnostic
doctor anywhere
doctor anywhere revenue
elon musk
emerging tech
emerging tech team
extreme
fda
google
health startup southeast asia
infectious disease
investing
kleiner perkins
life sciences
lim wai mun
mammoth biosciences
markets
mayfield
medical devices
medici
medicine
national blog main
national top stories
neuralink
news
nfx
What
expects
4
×
big
address
agency
aims
appeared
application
approval
arm
asian
available
based
bio
biosciences
blockchain
brain
buyout
cas
cheaper
chief
chip
claims
commerce
crispr
develop
device
diagnostics
doctor
double
dozens
drive
efforts
elon
extremetech
faster
fda
february
giant
healthcare
healthtech
Language
unset
4
×
Current search:
expects
×
unset
×
@techinasia.com
1 year ago
Doctor Anywhere aims to double revenue to S$100m this year
@extremetech.com
1 year ago
FDA Reportedly Rejected Elon Musk’s Neuralink Brain Chip Trial Over Safety Risks
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@coindesk.com
5 years ago
Overstock Venture Chief Expects Market for Blockchain Products in 2019
